United Therapeutics Corporation (UTHR) vs Zimmer Biomet Holdings, Inc. (ZBH)
A side-by-side comparison of United Therapeutics Corporation and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 4, 2026. Differences are shown without an overall score or investment verdict.
UTHR
United Therapeutics Corporation
$517.10HealthcareDelayed quote: Aug 4, 2026, 10:50 AM EDT
ZBH
Zimmer Biomet Holdings, Inc.
$95.10HealthcareDelayed quote: Aug 4, 2026, 10:50 AM EDT
Total return — UTHR vs ZBH
growth of $100 · dividends reinvested · last 25yUTHR +8167.6%ZBH +280.3%UTHR compounded faster
Log scale — wide-divergence pair
UTHR ZBH
UTHR vs ZBH: by the numbers
- •UTHR is the larger company ($21.95B vs $18.40B market cap).
- •UTHR trades at the lower trailing earnings multiple (19.09 vs 25.19 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (40.61% vs 9.05% net margin).
- •UTHR grew revenue faster over the past five years (16.05% vs 4.21% CAGR).
- •ZBH pays a dividend (0.99% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | UTHR | ZBH |
|---|---|---|
| P/E ratio | 19.09 | 25.19 |
| Forward P/E | 18.52 | 11.43 |
| P/S ratio | 7.69 | 2.26 |
| P/B ratio | 4.13 | 1.50 |
| PEG ratio | 1.16 | N/A |
| EV / EBITDA | 15.27 | 11.25 |
| FCF yield | 4.17% | 9.66% |
Profitability
| Metric | UTHR | ZBH |
|---|---|---|
| Gross margin | 86.58% | 61.62% |
| Operating margin | 45.34% | 15.61% |
| Net margin | 40.61% | 9.05% |
| ROE | 21.82% | 6.01% |
| ROIC | 16.13% | 5.48% |
Dividends
| Metric | UTHR | ZBH |
|---|---|---|
| Dividend yield | N/A | 0.99% |
| Payout ratio | N/A | 26.97% |
Growth (annualized)
| Metric | UTHR | ZBH |
|---|---|---|
| Revenue CAGR (5Y) | 16.05% | 4.21% |
| EPS CAGR (5Y) | 20.93% | N/A |
| FCF CAGR (5Y) | 12.12% | 15.41% |
| Total return CAGR (5Y) | 23.37% | -7.45% |
Frequently asked
- Which has the lower trailing P/E, UTHR or ZBH?
- UTHR has the lower trailing P/E: UTHR trades at 19.09 and ZBH at 25.19. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, UTHR or ZBH?
- Over the past five years, UTHR grew revenue faster — UTHR at a 16.05% CAGR versus ZBH at 4.21%.
- Does UTHR or ZBH pay a bigger dividend?
- ZBH pays a dividend (0.99% yield), while UTHR has no payments in the available dividend history.
- Is UTHR or ZBH more profitable?
- UTHR runs the higher net margin — UTHR at 40.61% versus ZBH at 9.05%.
- How have UTHR and ZBH total returns compared?
- Over the past 10 years, UTHR delivered 15.25% and ZBH delivered -1.82% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
United Therapeutics P/E ratioZimmer Biomet P/E ratioUnited Therapeutics dividend yieldZimmer Biomet dividend yieldUnited Therapeutics ROEZimmer Biomet ROEUnited Therapeutics operating marginZimmer Biomet operating marginUnited Therapeutics revenue growthZimmer Biomet revenue growthUnited Therapeutics free cash flowZimmer Biomet free cash flow
United Therapeutics & Zimmer Biomet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 4, 2026.